ELR positive CXCL chemokines are highly expressed in an animal model of ulcerative colitis

References

• Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12(suppl_1):S3–S9. doi:10.1097/01.mib.0000195385.19268.6816378007
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn’s disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999;149(10):916–924. doi:10.1093/oxfordjournals.aje.a00973510342800
   PubMed Web of Science ®Google Scholar
• Monteleone G, Caruso R, Pallone F. Targets for new immunomodulation strategies in inflammatory bowel disease. Autoimmun Rev. 2014;13(1):11–14. doi:10.1016/j.autrev.2013.06.00323774108
   PubMed Web of Science ®Google Scholar
• Bamias G, Pizarro TT, Cominelli F. Pathway-based approaches to the treatment of inflammatory bowel disease. Transl Res. 2016;167(1):104–115. doi:10.1016/j.trsl.2015.09.00226408803
   PubMed Web of Science ®Google Scholar
• Mas-Moya J, Singhi AD. The gross pathology of inflammatory bowel disease. Diagn Histopathol. 2015;21(7):261–266. doi:10.1016/j.mpdhp.2015.07.001
   Google Scholar
• Moura FA, de Andrade KQ, Dos Santos JCF, Araújo ORP, Goulart MOF. Antioxidant therapy for treatment of inflammatory bowel disease: does it work? Redox Biol. 2015;6:617–639. doi:10.1016/j.redox.2015.10.00626520808
   PubMed Web of Science ®Google Scholar
• Sallusto F, Baggiolini M. Chemokines and leukocyte traffic. Nat Immunol. 2008;9(9):949. doi:10.1038/ni.f.21418711431
   PubMed Web of Science ®Google Scholar
• Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392(6676):565. doi:10.1038/333409560152
   PubMed Web of Science ®Google Scholar
• Scholten D, Canals M, Maussang D, et al. Pharmacological modulation of chemokine receptor function. Br J Pharmacol. 2012;165(6):1617–1643. doi:10.1111/j.1476-5381.2011.01551.x21699506
   PubMed Web of Science ®Google Scholar
• Chemokine C. Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res. 2002;22:1067–1068. doi:10.1089/10799900276062430512433287
   PubMed Web of Science ®Google Scholar
• Clark-Lewis I, Dewald B, Geiser T, Moser B, Baggiolini M. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci. 1993;90(8):3574–3577. doi:10.1073/pnas.90.8.35748475106
   PubMed Web of Science ®Google Scholar
• Cotton J, Platnich J, Muruve D, Jijon H, Buret A, Beck P. Interleukin-8 in gastrointestinal inflammation and malignancy: induction and clinical consequences. Int J Interferon Cytokine Mediat Res. 2016;8:13–34.
   Google Scholar
• Strieter RM, Polverini PJ, Kunkel SL, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem. 1995;270(45):27348–27357. doi:10.1074/jbc.270.45.273487592998
   PubMed Web of Science ®Google Scholar
• Singh UP, Singh NP, Murphy EA, et al. Chemokine and cytokine levels in inflammatory bowel disease patients. Cytokine. 2016;77:44–49. doi:10.1016/j.cyto.2015.10.00826520877
   PubMed Web of Science ®Google Scholar
• Mascolo N, Izzo AA, Autore G, Maiello FM, Di Carlo G, Capasso F. Acetic acid-induced colitis in normal and essential fatty acid deficient rats. J Pharmacol Exp Ther. 1995;272(1):469–475.7815363
   PubMed Web of Science ®Google Scholar
• Randhawa PK, Singh K, Singh N, Jaggi AS. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol. 2014;18(4):279–288. doi:10.4196/kjpp.2014.18.4.27925177159
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C T method. Nat Protoc. 2008;3(6):1101. doi:10.1038/nprot.2008.7318546601
   PubMed Web of Science ®Google Scholar
• Chin AC, Parkos CA. Pathobiology of neutrophil transepithelial migration: implications in mediating epithelial injury. Annu Rev Pathol Mech Dis. 2007;2:111–143. doi:10.1146/annurev.pathol.2.010506.091944
   PubMed Web of Science ®Google Scholar
• Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol. 2001;159(6). doi:10.1016/S0002-9440(10)63051-9
   PubMed Web of Science ®Google Scholar
• Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn’s disease. J Pathol. 2003;199(1):28–35. doi:10.1002/(ISSN)1096-989612474223
   PubMed Web of Science ®Google Scholar
• Autschbach F, Giese T, Gassler N, et al. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn’s disease. Virchows Archiv. 2002;441(5):500–513. doi:10.1007/s00428-002-0684-z12447682
   PubMed Web of Science ®Google Scholar
• Gijsbers K, Van Assche G, Joossens S, et al. CXCR1‐binding chemokines in inflammatory bowel diseases: down‐regulated IL‐8/CXCL8 production by leukocytes in Crohn’s disease and selective GCP‐2/CXCL6 expression in inflamed intestinal tissue. Eur J Immunol. 2004;34(7):1992–2000. doi:10.1002/eji.20032480715214047
   PubMed Web of Science ®Google Scholar
• Cole KE, Strick CA, Paradis TJ, et al. Interferon–inducible T cell alpha chemoattractant (I-TAC): a novel Non-ELR CXC Chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med. 1998;187(12):2009–2021. doi:10.1084/jem.187.12.20099625760
   PubMed Web of Science ®Google Scholar
• Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM. Cutting edge: IFN-inducible ELR− CXC chemokines display defensin-like antimicrobial activity. J Immunol. 2001;167(2):623–627.11441062
   PubMed Web of Science ®Google Scholar
• Song F, Ito K, Denning TL, et al. Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: effects of flora and proinflammatory cytokines. J Immunol. 1999;162(4):2275–2280.9973504
   PubMed Web of Science ®Google Scholar
• Egesten A, Eliasson M, Olin AI, et al. The proinflammatory CXC-chemokines GRO-α/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. Int J Colorectal Dis. 2007;22(12):1421–1427. doi:10.1007/s00384-007-0370-317703315
   PubMed Web of Science ®Google Scholar
• Shea-Donohue T, Thomas K, Cody MJ, et al. Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-α), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun. 2008;14(2):117–124. doi:10.1177/175342590808872418713728
   PubMed Web of Science ®Google Scholar
• Standiford TJ, Kunkel SL, Lukacs NW, et al. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J Immunol. 1995;155(3):1515–1524.7636213
   PubMed Web of Science ®Google Scholar
• Ohtsuka Y, Lee J, Stamm D, Sanderson I. MIP-2 secreted by epithelial cells increases neutrophil and lymphocyte recruitment in the mouse intestine. Gut. 2001;49(4):526–533. doi:10.1136/gut.49.4.52611559650
   PubMed Web of Science ®Google Scholar
• Drew JE, Mayer C-D, Farquharson AJ, Young P, Barrera LN. Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue. J Mol Diagn. 2011;13(2):233–242. doi:10.1016/j.jmoldx.2010.10.00121354059
   PubMed Web of Science ®Google Scholar
• Ye L, Zhang Y-P, Yu N, Jia Y-X, Wan S-J, Wang F-Y. Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: a pilot study. Medicine. 2017;96(11):e6323.28296751
   PubMed Web of Science ®Google Scholar
• Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375(9715):657–663. doi:10.1016/S0140-6736(09)61963-220149425
   PubMed Web of Science ®Google Scholar
• Z’Graggen K, Walz A, Mazzucchelli L, Strieter RM, Mueller C. The CXC chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology. 1997;113(3):808–816.9287972
   PubMed Web of Science ®Google Scholar
• Lukacs N, Kunkel S, Allen R, et al. Stimulus and cell-specific expression of CXC and CC chemokines by pulmonary stromal cell populations. Am J Physiol Lung Cell Mol Physiol. 1995;268(5):L856–L861. doi:10.1152/ajplung.1995.268.5.L856
   Web of Science ®Google Scholar
• Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med. 1991;174(6):1355–1362. doi:10.1084/jem.174.6.13551744577
   PubMed Web of Science ®Google Scholar
• Strieter R, Kunkel S, Burdick M, Lincoln P, Walz A. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol Invest. 1992;21(6):589–596.1428026
   PubMed Web of Science ®Google Scholar
• Alzoghaibi MA, Al‐Mofleh IA, Al‐Jebreen AM. Neutrophil chemokines GCP‐2 and GRO‐α in patients with inflammatory bowel disease. J Dig Dis. 2008;9(3):144–148.18956592
   PubMed Web of Science ®Google Scholar
• Østvik AE, Granlund A, Bugge M, et al. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation. Inflamm Bowel Dis. 2012;19(2):265–274. doi:10.1002/ibd.23034
   Web of Science ®Google Scholar
• Uguccioni M, Gionchetti P, Robbiani DF, et al. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol. 1999;155(2):331–336. doi:10.1016/S0002-9440(10)65128-010433925
   PubMed Web of Science ®Google Scholar
• Lacher M, Kappler R, Berkholz S, Baurecht H, von Schweinitz D, Koletzko S. Association of a CXCL9 polymorphism with pediatric Crohn’s disease. Biochem Biophys Res Commun. 2007;363(3):701–707. doi:10.1016/j.bbrc.2007.09.02017892861
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen X, Wang X, et al. Chemokine CXCL11 links microbial stimuli to intestinal inflammation. Clin Exp Immunol. 2011;164(3):396–406. doi:10.1111/j.1365-2249.2011.04382.x21438871
   PubMed Web of Science ®Google Scholar
• Dwinell MB, Lügering N, Eckmann L, Kagnoff MF. Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology. 2001;120(1):49–59.11208713
   PubMed Web of Science ®Google Scholar
• Mikami S, Nakase H, Yamamoto S, et al. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis. J Pharmacol Exp Ther. 2008;327(2):383–392. doi:10.1124/jpet.108.14108518716065
   PubMed Web of Science ®Google Scholar
• Dotan I, Werner L, Vigodman S, et al. CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system. Inflamm Bowel Dis. 2009;16(4):583–592. doi:10.1002/ibd.21106
   Web of Science ®Google Scholar
• Carlsen H, Baekkevold E, Johansen F, Haraldsen G, Brandtzaeg P. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut. 2002;51(3):364–371. doi:10.1136/gut.51.3.36412171958
   PubMed Web of Science ®Google Scholar
• Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell–attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med. 1998;187(4):655–660. doi:10.1084/jem.187.4.6559463416
   PubMed Web of Science ®Google Scholar
• Yeung MM, Melgar S, Baranov V, et al. Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-γδ expression. Gut. 2000;47(2):215–227. doi:10.1136/gut.47.2.21510896913
   PubMed Web of Science ®Google Scholar
• Kurth I, Willimann K, Schaerli P, Hunziker T, Clark-Lewis I, Moser B. Monocyte selectivity and tissue localization suggests a role for breast and kidney–expressed chemokine (BRAK) in macrophage development. J Exp Med. 2001;194(6):855–862. doi:10.1084/jem.194.6.85511561000
   PubMed Web of Science ®Google Scholar
• Rajasekaran G, Kumar SD, Nam J, et al. Antimicrobial and anti-inflammatory activities of chemokine CXCL14-derived antimicrobial peptide and its analogs. Biochimica Et Biophysica Acta (Bba)-Biomembranes. 2019;1861(1):256–267.29959905
   PubMed Web of Science ®Google Scholar
• Maravillas-Montero JL, Burkhardt AM, Hevezi PA, Carnevale CD, Smit MJ, Zlotnik A. Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17. J Immunol. 2015;194(1):29–33. doi:10.4049/jimmunol.140170425411203
   PubMed Web of Science ®Google Scholar